BOGLE INVESTMENT MANAGEMENT L P /DE/ - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$462,000
-63.2%
29,636
-55.2%
0.73%
+671.6%
Q1 2018$1,256,000
-92.1%
66,111
-93.2%
0.10%
-91.8%
Q4 2017$15,844,000
+1.4%
966,128
-7.2%
1.16%
+9.4%
Q3 2017$15,622,000
+349.7%
1,041,478
+163.7%
1.06%
+320.6%
Q2 2017$3,474,000394,8770.25%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders